Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Impact of Mutational Burden and IPSS-M on Response to ESAs in Lower Risk Myelodysplastic Neoplasms

Blood (2023) 142 (Supplement 1): 4595.

https://doi.org/10.1182/blood-2023-189053

Published: 2023

Journal Articles

Characteristics and Distribution of Erythroid Progenitors and Precursors Correlate with Erythropoiesis Stimulating Agents (ESAs) Response in Lower Risk Myelodysplastic Syndromes

Marco Gabriele Gabriele Raddi, Sara Bencini, Benedetta Peruzzi, Roberto Caporale, Angela Consagra, Enrico Attardi, Luca Rigodanza, Cristina Amato, Alessandro Sanna, Alice Brogi, Elena Tofacchi, Margherita Cassari, Sven de Pourcq, Giorgio Mattiuz, Francesco Annunziato, Valeria Santini

Blood (2022) 140 (Supplement 1): 9777–9778.

https://doi.org/10.1182/blood-2022-157506

Published: 2022

Journal Articles

The Combination of Decitabine Plus Venetoclax Is an Active Salvage Therapy for AML Post HR-MDS Progressed during Treatment with Azacitidine Based Regimens

Angela Consagra, Alessandro Sanna, Marco Gabriele Raddi, Luca Rigodanza, Enrico Attardi, Cristina Amato, Margherita Cassari, Elena Tofacchi, Giorgio Mattiuz, Sven de Pourcq, Valeria Santini

Blood (2022) 140 (Supplement 1): 11738–11739.

https://doi.org/10.1182/blood-2022-169192

Published: 2022

Journal Articles

Treatment with Oral Azacitidine in Elderly Patients with Higher Risk Myelodysplastic Syndromes after Response to Subcutaneous Azacitidine

Valeria Santini, Cristina Amato, Barbara Caciagli, Angela Consagra, Luca Rigodanza, Sven de Pourcq, Margherita Cassari, Elena Tofacchi, Giorgio Mattiuz, Marco Gabriele Gabriele Raddi, Alessandro Sanna

Blood (2022) 140 (Supplement 1): 12313–12314.

https://doi.org/10.1182/blood-2022-169090

Published: 2022